BACKGROUND: Responses following BRCA1/2 genetic testing are relevant for the comprehension of risk status and may play a role in risk management decision making. The objective of this study was to evaluate a psychosocial telephone counseling (PTC) intervention delivered to BRCA1/2 mutation carriers following standard genetic counseling (SGC). We examined the effect of the intervention on distress and the concerns related to genetic testing. METHODS: This prospective randomized clinical trial included 90 BRCA1/2 mutation carriers. We measured anxiety, depression, and genetic testing distress outcomes at intervention baseline and 6 and 12 months following disclosure. We evaluated the effects of SGC versus SGC plus PTC on psychological outcomes using intention-to-treat analyses through generalized estimating equations. RESULTS: At 6 months, PTC reduced depressive symptoms (Z = -2.25, P = 0.02) and genetic testing distress (Z = 2.18, P = 0.02) compared with SGC. Furthermore, women in the intervention condition reported less clinically significant anxiety at 6 months (chi(2)(1) = 4.11, P = 0.04) than women who received SGC. We found no differences in outcomes between the intervention groups at the 12-month follow-up. CONCLUSIONS: As an adjunct to SGC, PTC delivered following disclosure of positive BRCA1/2 test results seems to offer modest short-term benefits for distress and anxiety. These results build upon a growing literature of psychosocial interventions for BRCA1/2 carriers and, given the potential impact of affect on risk management decision making, suggest that some carriers may derive benefits from adjuncts to traditional genetic counseling.
RCT Entities:
BACKGROUND: Responses following BRCA1/2 genetic testing are relevant for the comprehension of risk status and may play a role in risk management decision making. The objective of this study was to evaluate a psychosocial telephone counseling (PTC) intervention delivered to BRCA1/2 mutation carriers following standard genetic counseling (SGC). We examined the effect of the intervention on distress and the concerns related to genetic testing. METHODS: This prospective randomized clinical trial included 90 BRCA1/2 mutation carriers. We measured anxiety, depression, and genetic testing distress outcomes at intervention baseline and 6 and 12 months following disclosure. We evaluated the effects of SGC versus SGC plus PTC on psychological outcomes using intention-to-treat analyses through generalized estimating equations. RESULTS: At 6 months, PTC reduced depressive symptoms (Z = -2.25, P = 0.02) and genetic testing distress (Z = 2.18, P = 0.02) compared with SGC. Furthermore, women in the intervention condition reported less clinically significant anxiety at 6 months (chi(2)(1) = 4.11, P = 0.04) than women who received SGC. We found no differences in outcomes between the intervention groups at the 12-month follow-up. CONCLUSIONS: As an adjunct to SGC, PTC delivered following disclosure of positive BRCA1/2 test results seems to offer modest short-term benefits for distress and anxiety. These results build upon a growing literature of psychosocial interventions for BRCA1/2 carriers and, given the potential impact of affect on risk management decision making, suggest that some carriers may derive benefits from adjuncts to traditional genetic counseling.
Authors: M Dorval; A F Patenaude; K A Schneider; S A Kieffer; L DiGianni; K J Kalkbrenner; J I Bromberg; L A Basili; K Calzone; J Stopfer; B L Weber; J E Garber Journal: J Clin Oncol Date: 2000-05 Impact factor: 44.544
Authors: Chanita Hughes; Caryn Lerman; Marc Schwartz; Beth N Peshkin; Lari Wenzel; Steven Narod; Camille Corio; Kenneth P Tercyak; Danielle Hanna; Claudine Isaacs; David Main Journal: Am J Med Genet Date: 2002-01-15
Authors: David Cella; Chanita Hughes; Amy Peterman; Chih-Hung Chang; Beth N Peshkin; Marc D Schwartz; Lari Wenzel; Amy Lemke; Alfred C Marcus; Caryn Lerman Journal: Health Psychol Date: 2002-11 Impact factor: 4.267
Authors: I Sandanger; T Moum; G Ingebrigtsen; T Sørensen; O S Dalgard; D Bruusgaard Journal: Soc Psychiatry Psychiatr Epidemiol Date: 1999-01 Impact factor: 4.328
Authors: Kristi D Graves; Rhoda Gatammah; Beth N Peshkin; Ayelet Krieger; Christy Gell; Heiddis B Valdimarsdottir; Marc D Schwartz Journal: Fam Cancer Date: 2011-06 Impact factor: 2.375
Authors: Marc D Schwartz; Claudine Isaacs; Kristi D Graves; Elizabeth Poggi; Beth N Peshkin; Christy Gell; Clinton Finch; Scott Kelly; Kathryn L Taylor; Lauren Perley Journal: Cancer Date: 2011-06-29 Impact factor: 6.860
Authors: Stephanie A Cohen; Monica L Marvin; Bronson D Riley; Hetal S Vig; Julie A Rousseau; Shanna L Gustafson Journal: J Genet Couns Date: 2013-04-25 Impact factor: 2.537
Authors: Erin L O'Hea; Alexandra Cutillo; Laura Dietzen; Tina Harralson; Grant Grissom; Sharina Person; Edwin D Boudreaux Journal: Contemp Clin Trials Date: 2013-02-07 Impact factor: 2.226